MedImpact Receives Patents for Pharmacy Benefit Management Innovations

MedImpact Receives Patents for Pharmacy Benefit Management Innovations

<0> MedImpact Healthcare Systems, Inc.Dana H. Felthouse, Vice President of Marketing858-790-6684 </0>

, the nation’s largest privately held pharmacy benefit manager, has been awarded three patents from the United States Patent and Trademark Office (USPTO) for technological innovations in drug benefit management.

“The intellectual property of these patents is imbedded into MedImpact’s information technology and work processes for delivering state-of-the-art drug benefit programs,” said Greg Watanabe, MedImpact president. “Our patented innovations contribute to the low net cost drug trend performance experienced by our customers who are the nation’s leading managed care organizations, hospitals and employers.”

The company’s System for Pre-processing Drug Benefit Claims According to Processed Drug Lists filters and sorts pharmacy claims to support proper adjudication and reporting for Medicare Part D. This facilitates Part D drug determination, claims adjudication, and Prescription Drug Event (PDE) reporting by distinguishing various drug types and identifying claims scenarios that require special coverage rules such as Medicare Part B versus Part D and protected class drugs.

“The MedImpact customers who serve more than 500,000 Medicare beneficiaries benefit economically from our operational expertise and compliance excellence resulting from this pre-processing methodology,” said Watanabe. MedImpact’s PDE acceptance rate has been higher than the industry average annually since the program’s inception. The PBM’s year-to-date (YTD) PDE acceptance rate is 99.75% compared to industry average of 99.67%. Every 0.01% increase in YTD 2012 PDE acceptance equates to $230,000 in additional Part D reconciliation based on MedImpact book of business data.

MedImpact also received patents for:

, is the nation's largest full-service PBM that derives revenue by managing the drug benefit, not from dispensing drugs. We use information technology and human capital to improve the practice of managed care pharmacy. MedImpact partners with the nation's finest health plans, hospitals and employers to provide pharmacy benefit management services to more than 35 million members. Our membership includes more than 23.2 million members in managed pharmacy benefit plans with the balanced enrolled in discount and other drug assistance programs.

Suggested Articles

While Republicans are blasting Nancy Pelosi's drug plan as socialist, hospitals and insurers are finding a lot to like.

MA plans want to offer supplemental benefits but warn that the additional flexibilities offered by the feds may not be enough to really target beneficiaries.…

Industry efforts to lift a ban on using federal funding for a unique patient identifier hit a roadblock in the Senate Wednesday.